Abiopharma

🔍 Anderson Joel D (Director)

Company: Petco Health & Wellness Company, Inc. (WOOF)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 2,861 shares of Class A Common Stock at $2.45 per share (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,893,014.00 | transaction_form_type: 5 | Footnotes: F1, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By 2020 Trust | shares_owned_after: 2,429,235.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By 2025 Trust | shares_owned_after: 229,204.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Revocable Trust | shares_owned_after: 260,903.00

Footnotes:

• F1: These shares of Class A common stock of the Issuer were acquired under the Petco Health and Wellness Company, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
• F2: Includes 1,879,053 outstanding restricted stock units ("RSUs") granted under the Petco Health and Wellness Company, Inc. 2021 Equity Incentive Plan. Each RSU represents the right to receive one share of Class A common stock of the Issuer.